@article{2d7e023442834328bbf7d8dea07a3104,
title = "Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH",
abstract = "Patients with cancer have an increased risk of thrombosis requiring anticoagulants and/or antiplatelet agents, and they can also encounter thrombocytopenia due to cancer itself or cancer therapies. They often undergo many procedures such as tissue or bone marrow biopsies, placement of central access lines, diagnostic or therapeutic draining procedures, lumbar puncture, and more. Management of antithrombotic agents or thrombocytopenia around the time of these procedures is highly variable. In this document, the Hemostasis and Malignancy Subcommittee of the International Society on Thrombosis and Haemostasis aims to provide useful practice guidance in the management of antithrombotic agents and thrombocytopenia around the time of common procedures in patients with cancer.",
keywords = "anticoagulation, antiplatelet, biopsy, cancer, procedure, thrombocytopenia",
author = "Wang, {Tzu Fei} and Sanfilippo, {Kristen M.} and James Douketis and Anna Falanga and John Karageorgiou and Anthony Maraveyas and Ortel, {Thomas L.} and Gerald Soff and Suresh Vedantham and Zwicker, {Jeffrey I.}",
note = "Funding Information: T.‐F. Wang reports research funding from Leo Pharma; advisory board/honoraria: Servier and Valeo. K.M. Sanfilippo has received research funds from AstraZeneca (paid to the institution), Astellas Pharma Global (paid to the institution), American Cancer Society Institutional Research Grant‐18‐158‐61‐04, and National Institute of Health 1K01HL136893–01; honoraria for consultancy from Health Services Advisory Group; honoraria for expert case review from Covington & Burling, all outside the submitted work. J.I. Zwicker reports research support from Incyte and Quercegen; consultancy: Sanofi, CSL, Parexel; honoraria/advisory boards: Pfizer/BMS, Portola, Daiichi. S. Vedantham reports grant support from NHLBI. T.L. Ortel reports research support from NIH, CDC, Instrumentation Laboratory, Stago, and Siemens; royalties from UpToDate. A. Falanga reports honoraria: Sanofi, Bayer, Leo Pharma, Roche. The other authors report no conflicts of interest. Publisher Copyright: {\textcopyright} 2022 International Society on Thrombosis and Haemostasis.",
year = "2022",
month = dec,
doi = "10.1111/jth.15896",
language = "English",
volume = "20",
pages = "3026--3038",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
number = "12",
}